Regulacje i polityka gospodarcza · 16/11/2017
Becton Dickinson to Get Exclusive Patent License for Antineoplastic Drug Detection Kits
The National Institute of Allergy and Infectious Diseases is considering granting an exclusive patent commercialization license to Becton Dickinson to develop and commercialize Direct Reading Detection Kits for detecting surface contamination by antineoplastic drugs.